期刊文献+

促红细胞生成素对大鼠脑组织缺血再灌注海马CA1区神经元的作用 被引量:3

Effects of erythropoietin on neurons in CA1 region of hippocampus in rats with cerebral ischermia reperfusion injury
下载PDF
导出
摘要 目的:观察促红细胞生成素对缺血再灌注大鼠脑组织海马CA1区神经元数量以及凋亡细胞数量变化、热休克蛋白70表达的影响。方法:实验于2003-03/2004-12在解放军第三军医大学新桥医院中心实验室完成。选择健康清洁级Wistar大鼠66只,随机分为正常对照组6只、缺血再灌注生理盐水组30只(生理盐水对照组)、缺血再灌注促红细胞生成素组30只(促红细胞生成素治疗组)。线栓法制备大鼠大脑中动脉阻断局灶性脑缺血模型,缺血2h后再灌注,促红细胞生成素治疗组经腹腔按200U/kg注入生理盐水稀释的重组人红细胞生成素(200U/mL),生理盐水对照组经腹腔注入等量的生理盐水。再灌注后观察时相点为2,6,12,24,48h,应用苏木精-伊红染色观察脑海马CA1区细胞数量情况,应用末端脱氧核苷酸转移酶缺口标记法检测海马CA1区神经元凋亡情况,应用免疫组织化学法测定热休克蛋白70表达情况。结果:66只大鼠全部进入结果分析。①脑海马CA1区细胞的计数:生理盐水对照组再灌注后12,24,48h比正常对照组细胞数明显减少犤(268.6±44.5)个/视野,(240.8±22.5)个/视野,(201.8±30.7)个/视野,(337.3±45.3)个/视野,t=2.845~5.587,P<0.01犦,促红细胞生成素治疗组再灌注后12,24,48h比生理盐水对照组细胞数明显增加犤(286.7±33.8)个/视野,(271.9±30.4) AIM: To observe the effect of erythropoietin (EPO) on the numbers of apoptosis and neurons, and the expression of heat shock proteins 70 in CA1 region of hippocampus in rats with ischermia reperfusion injury. METHODS: The experiment was finished in the Center Laboratory,Xinqiao Hospital of Third Military Medical University of Chinese PLA from March 2003 to December 2004.Totally 66 Wistar rats were divided randomly into normal control group (n=6), ischermia reperfusion saline group (saline control group, n=30) and ischermia reperfusion EPO group (EPO treated group, n=30).Models of ischemia reperfusion were established after middle cerebral artery occlusion.After ischemia for two hours, rats in EPO treated group were injected with recombinant human erythropoietin(200 U/mL) diluted with saline into abdominal cavity, and the saline group received the same dose of saline. At the time points of 2, 6, 12, 24 and 48 hours following reperfusion,the number of cells in CA1 region of hippocampus was detected with Hematoxylin Eosin staining, the neuronal apoptosis was detected by using terminal deoxynucleotidyl transferase mediated nick end labeling staining,and the expression of HSP70 was detected by using immunohischemistry staining. RESULTS: All 66 rats were involved in the result.①After reperfusion for 12, 24 and 48 hours, the cellular number in saline control group(268.6±44.5, 240.8±22.5, 201.8±30.7) reduced significantly as compared with normal control group(337.3±45.3)(t=2.845-5.587,P< 0.01), which increased significantly in EPO treated group (286.7±33.8, 271.9±30.4, 258.3±29.5) as compared with saline control group(t=3.189-5.589, P< 0.01).②After reperfusion for 2, 6, 12, 24 and 48 hours, the TUNEL positive cellular number of saline control group (16.5±3.5, 28.4±6.5, 48.8±7.6, 60.7±10.2, 81.6±12.3) increased obviously as compared with normal control group(8.8±2.1) (t=2.985-6.324, P< 0.01), which decreased obviously in EPO treated group (12.7±3.4, 21.5±5.8, 32.7±4.6, 42.8±6.6, 51.8±9.5) as compared with saline control group (t=2.985-6.324,P< 0.01). ③After reperfusion for 2, 6, 12, 24 and 48 hours, the expression of HSP70 in saline control group (0.264±0.027, 0.328±0.053, 0.475±0.067, 0.587±0.095, 0.512±0.063) increased significantly as compared with normal control group (0.225±0.024) (t=3.254-6.028, P< 0.01). After reperfusion for 2, 6, 12 hours, the expression of HSP70 in EPO treated group(0.335±0.033, 0.448±0.055, 0.647±0.078) increased significantly as compared with saline control group(t=3.262-5.483,P< 0.01). CONCLUSION: EPO can alleviate neurons apoptosis in CA1 region of hippocampus in rats with focal ischermia reperfusion injury, and increase the expression of HSP70, so as to protect the nerve cells.
出处 《中国临床康复》 CSCD 北大核心 2005年第13期73-75,共3页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献10

  • 1郭伟莉,赵英贤,张巧俊,贾天成.促红细胞生成素对缺血性脑损伤的神经保护作用[J].中国临床康复,2003,7(5):783-784. 被引量:12
  • 2赵长安,周国平,李恩.慢性铝中毒大鼠端脑促红细胞生成素含量的变化及中药的防治作用(英文)[J].中国临床康复,2004,8(25):5468-5469. 被引量:2
  • 3Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20( 1 ): 84 - 91.
  • 4D' Ambrosio AL, Pinsky DJ, Connolly ES. The role of the complement cascade in ischemia/reperfusion injury: implications for neuroprotection. Mol Med 2001; 7(6): 367 - 82.
  • 5Blomgren K, Zhu C, Hallin U, et al. Mitochondria and ischemic reperfusion damage in the adult and in the developing brain. Biochem Biophys Res Commun 2003; 304(3): 551 -9.
  • 6Gassmann M, Heinicke K, Soliz J, et al. Non-erythroid functions of erythropoietin. Adv Exp Med Biol 2003; 543:323 - 30.
  • 7Celik M, Gokmen N, Erbayraktar S, et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 2002; 99(4): 2258 - 63.
  • 8Nishino K, Nowak TS Jr. Time course and cellular distribution of hsp27 and hsp72stress protein expression in a quantitative gerbil model of ischemic injury and tolerance: thresholds for hsp72 induction and hilar lesioning in the context of ischemic preconditioning. J Cereb Blood Flow Metab 2004; 24(2): 167 - 78.
  • 9Lepore DA, Knight KR, Anderson RL, et al. Role of priming stresses and Hsp70 in protection from ischemia-reperfusion injury in cardiac and skeletal muscle. Cell Stress Chaperones 2001; 6(2): 93 - 6.
  • 10Matouschek A, Pfanner N, Voos W. Protein unfolding by mitochondria. The Hsp70 import motor. EMBO Rep 2000; 1(5): 404 - 10.

二级参考文献18

  • 1[1]de Francisco AL, Fernsndez Fresnedo G, Rodrigo E,et al, past,present and futureof orythropoietin use in the elderly, Int Urol Nephrol 2002; 33(1): 187 -93
  • 2[2]Ruscher K, Freyer D, Karsch M, et al, Erythropoietin is a paracrine medistor of ischemic tolerance in the brain; evidence from an in vitro model. J Neurosci 2002;22(23): 10291 - 301
  • 3[3]Nishigakid,Hsnson C, Ohsshi T, THompson D, Muszynski, Ruscettis. ErythroidCells Rendered Erythropoietir Independent by Infection with Friend Spleen Focus-Forming Virus show Constitutive Activation of phosphatidylinositol 3-kinase and AKt kinssei Involvement of Insulin Receptor Substrute-Related Adapter Proteins . J uirol 2000 ;74(7): 3037 -45
  • 4[4]Masuda S, Okano M, Yamagishi K, et al. A novel site of erythropoietin production. J Biolo Chemic 1994: 269(30)19488-93
  • 5[5]Sakanaka M, Wen TC, Matsuda' S, et al. In vivo evidence that erythropoietin protects heuron from ischemic damage.Proc Natl Acad Sci USA 1998; 95(8):4635 - 40
  • 6[6]Bernaudin M, Marti HH, Rousse IS, ,et al. A potential role for erythropoietin in focal permanent cerbral ischemia in mice. J Cereb Blood Flow Metab 1999; 19(6): 643 - 51
  • 7[7]Juul S Erythropoietin in the central nervous system and its use to prevent hypoxic-ischemic brain damage.Acta Paediatr 2002; 91 (438): 36 - 42
  • 8[8]Chong ZZ,Kang JQ, Maiese K.Erythropoietin is a novel vascular protectantthrough activation of Akt-1 and mitochondrial modulation of cysteine proteases. Cireulation 2002; 106(23):2973 -9
  • 9[9]Ehrenreich H, Hasselblatt M, Dembowski C, et al Erythtopoietin therapy for acutestroke is both safe and beneficial.Mol Med 2002; 8 ( 8 ): 495 - 505
  • 10[10]Siren AL, Fratelli M, Brines M, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acod Sci USA 2001; 98(7):4044 -9

共引文献11

同被引文献33

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部